A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of unknown origin.
Several professionals said the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the platform has removed problematic content and prohibited related hashtags and search suggestions. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Research also discovered groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at residence.
After minutes of joining one group, a seller shared contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.
Item Details and Pricing
Within these communities, messages display dark colored parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has previously seen patients injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to possibly significant health risks”.
